查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1943240

可攝入式感測器市場－全球產業規模、佔有率、趨勢、機會及預測（按組件、感測器、垂直產業、地區和競爭格局分類，2021-2031年）

Ingestible Sensor Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Sensor, By Vertical, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球口服型感測器市場預計將從 2025 年的 24.9 億美元成長到 2031 年的 50.7 億美元，複合年成長率為 12.58%。

這些小型電子設備表面塗覆有生物相容性材料，可透過口服方式監測藥物依從性、胃腸道成像或監測內部生理指標。該市場的成長主要受慢性胃腸道疾病發病率上升以及對非侵入性診斷方法（作為傳統內視鏡檢查的替代方案）需求成長的驅動。此外，全球向數位化醫療解決方案和遠端患者監護的轉變也持續推動這些先進技術的應用。

市場概覽
預測期 2027-2031
市場規模：2025年 24.9億美元
市場規模：2031年 50.7億美元
複合年成長率：2026-2031年 12.58%
成長最快的細分市場 影像感測器
最大的市場 北美洲

然而，該行業面臨諸多障礙，複雜的採購流程和嚴格的監管程序會阻礙商業性准入。 Ⅱ類或III類醫療設備的核准需要大量的臨床檢驗，而這往往與過時的報銷體系相衝突。英國醫療技術產業協會的報告凸顯了這些挑戰，報告顯示，到2024年，監管的不確定性和不切實際的競標條件導致50%的受訪醫療技術公司推遲了新技術的引進。這些主要地區的障礙凸顯了將快速的技術進步與現有醫療保健框架相協調的困難。

市場促進因素

慢性心血管疾病和胃腸道疾病發病率的上升正在從根本上改變全球口服型感測器市場，對比傳統方法更精準的診斷工具的需求日益成長。隨著心律不整和功能性腸道疾病盛行率的增加，醫療保健機構正轉向使用口服型膠囊來獲取體內連續、即時的生理數據。根據Atmo Biosciences公司於2024年4月發布的關於一項關鍵性臨床試驗的新聞稿，全球約有40%的人口患有消化器官系統疾病，這使得全球迫切需要有效、非侵入性的診斷方法。不斷成長的患者群體迫使製造商擴大其設備的臨床應用範圍和目標年齡範圍。例如，Anx Robotica公司於2024年1月獲得FDA核准，用於兩歲及以上兒童的小腸視訊膠囊內視鏡系統。

另一個推動因素是遠端醫療和遠端患者監護解決方案需求的激增，這加速了口服型感測器在分散式醫療模式中的應用。隨著醫療系統尋求在家中治療慢性病並減少患者再次入院，感測膠囊和數位藥丸提供了一種無需醫療專業人員直接參與即可追蹤體內生命徵象和藥物依從性的檢驗方法。這種居家管理趨勢得到了快速普及的支持；HealthArc在2024年10月報告稱，到2024年，美國接受遠端患者監護的患者人數將成長至3000萬。可攝入式感測器正成為此基礎設施的關鍵組成部分，使醫生能夠遠端接收可操作的依從性數據，從而實現處方與患者依從性之間的閉迴路。

市場挑戰

嚴格的監管流程和複雜的採購程序給全球口服型感測器市場帶來了巨大挑戰。這些繁瑣的官僚障礙顯著延長了產品核可時間，並要求製造商對II類和III類醫療設備進行耗時耗資的臨床檢驗。因此，創新口服型技術的上市往往被推遲，限制了商業性應用，並減緩了醫療機構的採納速度。這種情況造成了很高的進入門檻，尤其對於缺乏資源來應對漫長上市前階段的中小型企業而言，最終會抑制產業競爭，並阻礙技術進步。

這些監管瓶頸帶來的負面影響因合規成本的不斷攀升而加劇，直接侵蝕了投資能力和利潤率。根據歐洲醫療技術協會（MedTech Europe）2024年的數據，在更新後的法規結構下，醫療設備的認證和維護成本將比舊標準增加高達100%。這種財務負擔的急劇增加迫使企業將資金從研發中轉移，直接阻礙了產業的創新能力。因此，非侵入性診斷工具的供應無法滿足日益成長的全球需求，限制了口腔感測器產業的擴充性和收入成長。

市場趨勢

用於微生物組分析的氣體感測膠囊的興起，標誌著胃腸道內成像技術從結構成像轉變為功能代謝譜分析的重要轉變。與依賴視覺確認異常的傳統內視鏡不同，這些口服感測器能夠識別特定的氣體生物標記物，例如甲烷和氫氣，從而提供有關發酵過程和腸道蠕動的即時數據。這項功能對於診斷小腸細菌過度生長（SIBO）等功能性疾病至關重要，因為這些疾病通常缺乏視覺指標。為了展示這項技術的臨床應用進展，Atmo Biosciences公司於2024年4月宣布，已成功完成一項涉及200多名受試者的關鍵性臨床試驗，證明了該膠囊在評估腸道轉運時間（局部和整體性）方面的有效性。

同時，融合機器學習和人工智慧的預測分析技術正透過自動化數據解讀，徹底革新口腔感測器的診斷能力。製造商正將先進的深度學習演算法整合到其感測器平台中，以快速分析海量的生理和影像數據，顯著縮短胃腸病學家解讀影像所需的時間，同時提高診斷準確率。這項技術整合解決了檢測細微病變時人為誤差這一重大挑戰。為了支持這一趨勢，AnX Robotica 於 2024 年 1 月宣布，其新近獲得 FDA 批准的小腸膠囊內視鏡人工智慧輔助解讀工具在臨床檢驗中，對個別患者分析的靈敏度達到了 99.88%。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球可攝入式感測器市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按組件分類（感測器、穿戴式貼片/資料記錄器、軟體）
    • 透過感測器（溫度感測器、壓力感測器、pH感測器、影像感測器）
    • 按行業（醫療、運動和健身）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美可攝入式感測器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲可攝入式感測器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區可攝入式感測器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲可攝入式感測器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲可攝入式感測器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球可攝入式感測器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • RF Co. Ltd
  • CapsoVision Inc.
  • Medtronic Inc
  • Olympus Corporation
  • Given Imaging Ltd.
  • Medimetrics
  • Microchips Biotech, Inc.
  • Check-Cap Ltd
  • IntroMedic Co., Ltd.
  • Sensirion AG

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20241

The Global Ingestible Sensor Market is projected to expand from USD 2.49 Billion in 2025 to USD 5.07 Billion by 2031, registering a CAGR of 12.58%. These devices, which are miniaturized electronics encased in biocompatible materials, are swallowed to track medication adherence, image the gastrointestinal tract, or monitor internal physiological metrics. The market is primarily propelled by the growing burden of chronic gastrointestinal conditions and a rising preference for non-invasive diagnostic options over conventional endoscopy. Additionally, the worldwide transition toward digitized healthcare solutions and remote patient monitoring continues to bolster the uptake of these advanced technologies.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.49 Billion
Market Size 2031USD 5.07 Billion
CAGR 2026-203112.58%
Fastest Growing SegmentImage Sensor
Largest MarketNorth America

However, the sector encounters considerable obstacles due to complex procurement procedures and strict regulatory pathways that can impede commercial access. Securing approval for these Class II or Class III medical devices demands extensive clinical validation, which frequently conflicts with antiquated reimbursement structures. Highlighting these difficulties, the Association of British HealthTech Industries reported in 2024 that regulatory ambiguity and unfeasible tender conditions caused 50% of surveyed health technology firms to postpone the launch of new innovations. These barriers in major regions underscore the challenge of harmonizing rapid technological progress with established healthcare frameworks.

Market Driver

The rising incidence of chronic cardiovascular and gastrointestinal diseases is fundamentally transforming the Global Ingestible Sensor Market, creating a strong demand for diagnostic tools that provide higher precision than traditional methods. As the prevalence of cardiac irregularities and functional gut disorders increases, healthcare providers are turning to ingestible capsules to obtain continuous, real-time physiological data from inside the body. According to an April 2024 media release by Atmo Biosciences regarding a pivotal clinical study, nearly 40% of the global population suffers from gastrointestinal issues, highlighting the urgent worldwide need for effective, non-invasive diagnostics. This growing patient volume is compelling manufacturers to broaden the clinical application and reach of their devices, as seen in January 2024 when AnX Robotica announced FDA clearance to use its Small Bowel Video Capsule Endoscopy system in patients as young as two years old.

A parallel catalyst is the surging demand for telehealth and remote patient monitoring solutions, which accelerates the incorporation of ingestible sensors into decentralized care models. As healthcare systems aim to treat chronic illnesses at home and reduce hospital readmissions, sensing capsules and digital pills offer a verifiable method to track internal vitals and medication adherence without direct clinician involvement. This trend toward home-based management is supported by rapid adoption rates; HealthArc reported in October 2024 that the number of patients in the United States using remote patient monitoring increased to 30 million in 2024. Ingestible sensors are becoming a crucial element of this infrastructure, allowing physicians to receive actionable compliance data remotely and closing the loop between prescription and patient adherence.

Market Challenge

Stringent regulatory pathways and intricate procurement processes present a major challenge for the Global Ingestible Sensor Market. These bureaucratic hurdles significantly prolong the time needed for product approval, requiring manufacturers to navigate expensive and lengthy clinical validation steps for Class II and Class III devices. Consequently, the launch of innovative ingestible technologies is often delayed, restricting their commercial availability and slowing their adoption by healthcare providers. This landscape establishes high entry barriers, especially for smaller firms lacking the resources to endure extended pre-market phases, which ultimately stifles competition and decelerates technological advancement within the industry.

The negative impact of these regulatory bottlenecks is intensified by rising compliance costs, which directly deplete investment capabilities and profit margins. Data from MedTech Europe in 2024 indicates that certification and maintenance expenses for medical devices under updated regulatory frameworks have jumped by up to 100% compared to previous standards. This sharp increase in financial burden forces companies to divert capital away from research and development, directly impeding the industry's capacity to innovate. As a result, the market struggles to match the supply of non-invasive diagnostic tools with growing global demand, limiting the scalability and revenue growth of the ingestible sensor sector.

Market Trends

The rise of gas-sensing capsules for microbiome analysis represents a significant evolution from structural imaging to functional metabolic profiling within the gastrointestinal tract. Unlike traditional endoscopy, which depends on visual confirmation of abnormalities, these ingestible sensors identify specific gaseous biomarkers like methane and hydrogen to provide real-time data on fermentation processes and gut motility. This functionality is essential for diagnosing functional disorders such as Small Intestinal Bacterial Overgrowth (SIBO), where visual indicators are often missing. Demonstrating the clinical advancement of this technology, Atmo Biosciences announced in April 2024 that it successfully completed a pivotal trial with over 200 subjects to validate the capsule's efficacy in assessing regional and whole gut transit time.

At the same time, the integration of machine learning and artificial intelligence for predictive analytics is revolutionizing the diagnostic capabilities of ingestible sensors by automating data interpretation. Manufacturers are embedding sophisticated deep learning algorithms into sensor platforms to rapidly analyze immense volumes of physiological and video data, drastically reducing the reading time for gastroenterologists while improving diagnostic precision. This technological convergence resolves the critical issue of human error in detecting subtle pathologies. Validating this trend, AnX Robotica announced in January 2024 that its newly FDA-cleared AI-assisted reading tool for small bowel capsule endoscopy achieved a 99.88% sensitivity in per-patient analysis during clinical validation.

Key Market Players

  • RF Co. Ltd
  • CapsoVision Inc.
  • Medtronic Inc
  • Olympus Corporation
  • Given Imaging Ltd.
  • Medimetrics
  • Microchips Biotech, Inc.
  • Check-Cap Ltd
  • IntroMedic Co., Ltd.
  • Sensirion AG

Report Scope

In this report, the Global Ingestible Sensor Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ingestible Sensor Market, By Component

  • Sensor
  • Wearable Patch/ Data Recorder
  • Software

Ingestible Sensor Market, By Sensor

  • Temperature Sensor
  • Pressure Sensor
  • pH Sensor
  • Image Sensor

Ingestible Sensor Market, By Vertical

  • Medical
  • Sports & Fitness

Ingestible Sensor Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ingestible Sensor Market.

Available Customizations:

Global Ingestible Sensor Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ingestible Sensor Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Sensor, Wearable Patch/ Data Recorder, Software)
    • 5.2.2. By Sensor (Temperature Sensor, Pressure Sensor, pH Sensor, Image Sensor)
    • 5.2.3. By Vertical (Medical, Sports & Fitness)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Ingestible Sensor Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Sensor
    • 6.2.3. By Vertical
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Ingestible Sensor Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Sensor
        • 6.3.1.2.3. By Vertical
    • 6.3.2. Canada Ingestible Sensor Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Sensor
        • 6.3.2.2.3. By Vertical
    • 6.3.3. Mexico Ingestible Sensor Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Sensor
        • 6.3.3.2.3. By Vertical

7. Europe Ingestible Sensor Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Sensor
    • 7.2.3. By Vertical
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Ingestible Sensor Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Sensor
        • 7.3.1.2.3. By Vertical
    • 7.3.2. France Ingestible Sensor Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Sensor
        • 7.3.2.2.3. By Vertical
    • 7.3.3. United Kingdom Ingestible Sensor Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Sensor
        • 7.3.3.2.3. By Vertical
    • 7.3.4. Italy Ingestible Sensor Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Sensor
        • 7.3.4.2.3. By Vertical
    • 7.3.5. Spain Ingestible Sensor Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Sensor
        • 7.3.5.2.3. By Vertical

8. Asia Pacific Ingestible Sensor Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Sensor
    • 8.2.3. By Vertical
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Ingestible Sensor Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Sensor
        • 8.3.1.2.3. By Vertical
    • 8.3.2. India Ingestible Sensor Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Sensor
        • 8.3.2.2.3. By Vertical
    • 8.3.3. Japan Ingestible Sensor Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Sensor
        • 8.3.3.2.3. By Vertical
    • 8.3.4. South Korea Ingestible Sensor Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Sensor
        • 8.3.4.2.3. By Vertical
    • 8.3.5. Australia Ingestible Sensor Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Sensor
        • 8.3.5.2.3. By Vertical

9. Middle East & Africa Ingestible Sensor Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Sensor
    • 9.2.3. By Vertical
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Ingestible Sensor Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Sensor
        • 9.3.1.2.3. By Vertical
    • 9.3.2. UAE Ingestible Sensor Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Sensor
        • 9.3.2.2.3. By Vertical
    • 9.3.3. South Africa Ingestible Sensor Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Sensor
        • 9.3.3.2.3. By Vertical

10. South America Ingestible Sensor Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Sensor
    • 10.2.3. By Vertical
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Ingestible Sensor Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Sensor
        • 10.3.1.2.3. By Vertical
    • 10.3.2. Colombia Ingestible Sensor Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Sensor
        • 10.3.2.2.3. By Vertical
    • 10.3.3. Argentina Ingestible Sensor Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Sensor
        • 10.3.3.2.3. By Vertical

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Ingestible Sensor Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. RF Co. Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. CapsoVision Inc.
  • 15.3. Medtronic Inc
  • 15.4. Olympus Corporation
  • 15.5. Given Imaging Ltd.
  • 15.6. Medimetrics
  • 15.7. Microchips Biotech, Inc.
  • 15.8. Check-Cap Ltd
  • 15.9. IntroMedic Co., Ltd.
  • 15.10. Sensirion AG

16. Strategic Recommendations

17. About Us & Disclaimer